147 related articles for article (PubMed ID: 29254801)
1. The associations between CYP24A1 polymorphisms and cancer susceptibility: A meta-analysis and trial sequential analysis.
Zhu M; Qiu S; Zhang X; Wang Y; Souraka TDM; Wen X; Liang C; Tu J
Pathol Res Pract; 2018 Jan; 214(1):53-63. PubMed ID: 29254801
[TBL] [Abstract][Full Text] [Related]
2. Association study between CYP24A1 gene polymorphisms and cancer risk.
Yi C; Huang C; Wang H; Wang C; Dong L; Gu X; Feng X; Chen B
Pathol Res Pract; 2020 Jan; 216(1):152735. PubMed ID: 31740231
[TBL] [Abstract][Full Text] [Related]
3. Genetic associations between
Zhang G; Jin M
Int J Biol Markers; 2020 Dec; 35(4):71-79. PubMed ID: 33050822
[TBL] [Abstract][Full Text] [Related]
4. The association study between CYP24A1 gene polymorphisms and risk of liver, lung and gastric cancer in a Chinese population.
Xiong Q; Jiao Y; Yang P; Liao Y; Gu X; Hu F; Chen B
Pathol Res Pract; 2020 Dec; 216(12):153237. PubMed ID: 33065483
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
[TBL] [Abstract][Full Text] [Related]
6. Association of the vitamin D metabolism gene GC and CYP27B1 polymorphisms with cancer susceptibility: a meta-analysis and trial sequential analysis.
Zhu M; Tan Z; Luo Z; Hu H; Wu T; Fang S; Wang H; Lu Z
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467173
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of CYP24A1 gene and cancer susceptibility: a meta-analysis including 40640 subjects.
Wang Y; Wang R; Yuan S; Liu X
World J Surg Oncol; 2023 Sep; 21(1):279. PubMed ID: 37670334
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk.
Cao S; Wei F; Zhou J; Zhu Z; Li W; Wu M
Breast Cancer Res Treat; 2020 Jan; 179(2):499-509. PubMed ID: 31696340
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in CYP24A1 Is Associated with Lung Cancer Risk: A Case-Control Study in Chinese Female Nonsmokers.
Qu R; Li X; Quan X; Xia L; Fang X; Li H; Zhou B
DNA Cell Biol; 2019 Mar; 38(3):243-249. PubMed ID: 30724597
[TBL] [Abstract][Full Text] [Related]
11. Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer Risk.
Wei Y; Wang X; Zhang Z; Xie M; Li Y; Cao H; Zhao X
Curr Mol Med; 2019; 19(8):579-588. PubMed ID: 31215377
[TBL] [Abstract][Full Text] [Related]
12. [Study on the association between CYP24A1 genetic polymorphisms and risks related to postmenopausal breast cancer].
Chen FX; Zhu Z; Cui L; Yu H; Han RQ; Luo PF; Zhou JY; Wu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jun; 41(6):934-939. PubMed ID: 32564563
[No Abstract] [Full Text] [Related]
13. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
[TBL] [Abstract][Full Text] [Related]
14. A candidate intronic
Sadeghi H; Nazemalhosseini-Mojarad E; Piltan S; Fazeli E; Moradi Y; Amin-Beidokhti M; Yassaee VR; Aghdaei HA; Zali MR; Mirfakhraie R
Biomark Med; 2020 Jan; 14(1):23-29. PubMed ID: 31802707
[No Abstract] [Full Text] [Related]
15. Contribution of CYP24A1 variants in coronary heart disease among the Chinese population.
Qian P; Cao X; Xu X; Duan M; Zhang Q; Huang G
Lipids Health Dis; 2020 Aug; 19(1):181. PubMed ID: 32762692
[TBL] [Abstract][Full Text] [Related]
16. Contribution of
Fam MS; Hassanein SI; Abdel Rahman MF; Assal RA; Hanafi RS; Gad MZ
Can J Physiol Pharmacol; 2019 Dec; 97(12):1152-1158. PubMed ID: 31398293
[TBL] [Abstract][Full Text] [Related]
17. Effects of VDR and CYP24A1 gene polymorphisms on the outcome of supraglottic larynx cancer.
Edizer DT; Leblebici A; Ergun U; Yilmaz F; Koc A; Basbinar Y; Ellidokuz EB
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2168-2178. PubMed ID: 38567579
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP24A1 gene polymorphism with colorectal cancer in the Jiamusi population.
Chai L; Ni J; Ni X; Zhang N; Liu Y; Ji Z; Zhao X; Zhu X; Zhao B; Xin G; Wang Y; Yang F; Sun L; Zhu X; Bao W; Shui X; Wang F; Chen F; Yang Z
PLoS One; 2021; 16(6):e0253474. PubMed ID: 34191826
[TBL] [Abstract][Full Text] [Related]
19. CYP24A1 rs1570669 Variant Has a Protective Effect against Tumors of the Urinary System.
Sun Y; Wang X; Wu J; Xiong Z; Li H; Liu Y; Liu J; Ding Y; Jin T
Public Health Genomics; 2020; 23(5-6):200-209. PubMed ID: 33113544
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D pathway gene variants and prostate cancer prognosis.
Holt SK; Kwon EM; Koopmeiners JS; Lin DW; Feng Z; Ostrander EA; Peters U; Stanford JL
Prostate; 2010 Sep; 70(13):1448-60. PubMed ID: 20687218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
